¥2,032.00
0.94%
Tokyo, Sep 25, 03:15 pm JST. Closed.
ISIN
JP3428850006
Symbol
4559

Zeria Pharmaceutical Stock price

¥2,035.00
-35.00 1.69% 1M
-121.00 5.61% 6M
-64.00 3.05% YTD
-57.00 2.72% 1Y
-269.00 11.68% 3Y
-107.00 5.00% 5Y
+364.00 21.78% 10Y
+1,066.82 110.19% 20Y
Tokyo, Closing price Fri, Sep 25 2026
+22.00 1.09%
ISIN
JP3428850006
Symbol
4559
Industry

Is Zeria Pharmaceutical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
¥85.0b
Enterprise Value
¥93.7b
Net debt
¥8.8b
Cash
¥27.7b
Shares outstanding
44.1m
Valuation (TTM | estimate)
P/E
10.8
P/S
0.9 | 0.9
EV/Sales
1.0 | 1.0
EV/FCF
-
P/B
0.8
Dividends
DPS
¥49.00
Yield 1Y | 5Y
2.4% | 2.0%
Growth 1Y | 5Y
4.3% | 7.6%
Payout 1Y | 3Y
25.6% | 23.6%
Increased
5 Years
Financials (TTM | estimate)
Revenue
¥91.1b | ¥95.4b
EBITDA
-
EBIT
¥12.8b
Net Income
¥8.2b
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
6.8% | 7.1%
EBITDA
-
EBIT
30.9%
Net Income
20.8%
Free Cash Flow
-
Margin
Gross
73.0%
EBITDA
-
EBIT
14.1%
Net
9.0%
Free Cash Flow
-
Financial Health
Equity Ratio
60.3%
Return on Equity
7.8%
ROCE
10.4%
ROIC
7.5%
Debt/Equity
0.3
More
EPS
¥186.7
FCF per Share
-
Short interest
-
Employees
2k
Rev per Employee
¥51.1m

Zeria Pharmaceutical Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Zeria Pharmaceutical forecast:

3x Hold
43%
4x Sell
57%

Analyst Opinions

7 Analysts have issued a Zeria Pharmaceutical forecast:

Hold
43%
Sell
57%

Financial data from Zeria Pharmaceutical

Jun '26
+/-
%
91,118 91,118
7% 7%
100%
- Direct Costs 24,615 24,615
5% 5%
27%
66,503 66,503
7% 7%
73%
- Selling and Administrative Expenses 53,698 53,698
3% 3%
59%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 12,805 12,805
31% 31%
14%
Net Profit 8,230 8,230
21% 21%
9%

In millions JPY.

Don't miss a Thing! We will send you all news about Zeria Pharmaceutical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Zeria Pharmaceutical Co., Ltd. engages in the manufacture, sale, import and export of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 1,777 full-time employees. The firm operates in two business segments. The Ethical Drug segment is engaged in the research, development, manufacture and sale of ethical drugs. The Consumer Healthcare segment is engaged in the manufacture, purchase and sale of over-the-counter (OTC) drugs, health foods, quasi drugs and cosmetics related to self-medication. The others include insurance agency business and real estate business, as well as various maintenance business such as purchasing and sale of promotional materials.

Head office Japan
CEO Mr. Ibe
Employees 1,746
Website www.zeria.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today